drugset / Trial / NCT02052999

Study to Evaluate the Efficacy and Safety of PAC-14028 Cream in Rosacea Patients

NCT02052999

Phase 2 Completed 80 enrolled Amorepacific Corporation
RandomizedParallel-groupOpen-labelTreatment

Summary

The objective of this study is to determine the efficacy and safety of PAC-14028 1% cream of Amorepacific Corporation in patients with erythema-telangiectatic or papulopustular rosacea

Timeline

Start
2013-02
Primary completion
2013-06
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Subject PAC-14028 Unknown 1 % Topical
Comparator Rozex Unknown 0.75 % Topical

Indications